The Short Version
Utah's Doctronic pilot is designed to eventually allow AI-driven prescription renewals without routine physician sign-off, but the claim significantly overstates current reality. As of early 2026, the program's active phase requires physician review of all renewals before they reach pharmacies. Even in later phases, escalation pathways to licensed physicians remain structurally embedded. The present-tense assertion of "no physician involvement" conflates the program's future autonomous design with its current operational requirements.